Search | Médecins Sans Frontières Access Campaign

About us
About the Access Campaign

Some of our 2023 plans

Media room

Latest news

Jobs
Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.
Our work
COVID-19

Explainer: A bold proposal at the WTO by India and South Africa

Diabetes

Drug-resistant infections

HIV/AIDS

Hepatitis C

Hypertension

Patents and intellectual property

Pandemic prevention, preparedness and response

The Patent Oppositions Database

Research and development

Spotlight on: the Big Pharma double-dip

Transparency Matters: Clinical Trials Costs

Tropical and neglected diseases

Spotlight on: Snakebite

Tuberculosis

Vaccines

Explainer: COVID-19 vaccines - Recommendations for equitable access
Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.
Get involved
Campaign success stories

#NoMoreTears Johnson & Johnson Can you hear us?

A Fair Shot

Novartis 'Drop the case'

Trans-pacific Partnership (TPP)

Recent campaigns

Time for $5

No Patents in a Pandemic

Share the Tech - Save Lives
Take Action

Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.
Resources
Press releases

Statements

Letters

Opinion articles

Feature stories

Interviews

Blog

Newsletters

Publications

Research articles

Topic overview pages

Spotlight pages

Videos

Photo stories

Infographics

Events
Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.

Medicines shouldn’t be a luxury Take action

3 results found
There are 8 active filters
Clear all filters
Tuberculosis
access to medicines
UN High Level Panel on Access to Medicines
Report
Statement

3 results found

Statement |

14 September 2017

MSF statement at the 67th session of the WHO Regional Committee for Europe

Tags Tuberculosis drug-resistant TB innovationresearch and development (R&D)UN High Level Panel on Access to Medicines World Health Organization

Statement |

28 March 2016

3P submission to UN High-Level Panel on Access to Medicines

Tags Tuberculosis tuberculosis 3Paccess to medicinesLife Prize

Report cover: Out of step

Report |

20 October 2014

Out of Step: Deadly implementation gaps in the TB response, 1st Ed., 2014

A survey of TB diagnostic and treatment practices in eight countries

Tags Tuberculosis drug-resistant TBtuberculosis access to medicines [TB] Out of Step Access Campaign